In patients at high risk of developing contrast medium nephropathy is evaluate renal safety after MRI-enhanced with Dotarem, compared with patients submit non enhanced MRI
RENAL SAFETY EVALUATION AFTER DOTAREM-ENHANCED-MRI COMPARED WITH NON-ENHANCED-MRI IN PATIENTS AT HIGH RISK OFDEVELOPING CONTRAST MEDIUM INDUCED NEPHROPATHY
CAMPIONI, Paolo;
2013
Abstract
In patients at high risk of developing contrast medium nephropathy is evaluate renal safety after MRI-enhanced with Dotarem, compared with patients submit non enhanced MRIFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.